Genialis provides therapeutic intelligence with its Supermodel of cancer biology. We develop and validate clinically actionable AI models informed by the world’s most ethnographically diverse cancer data sets to predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data. The company is headquartered in Houston, Boston and Ljubljana.